Filter
174
Text search:
African
Trypanosomiasis
Featured
Recommendations
16
New Publications
33
Language
Document type
No document type
71
Studies & Reports
58
Guidelines
14
Strategic & Response Plan
13
Manuals
8
Resource Platforms
4
Situation Updates
3
Infographics
1
Videos
1
Fact sheets
1
Countries / Regions
Africa
24
Global
19
Uganda
10
West and Central Africa
9
East and Southern Africa
8
Liberia
7
Middle East and North Africa
5
Sierra Leone
4
South Sudan
4
Zambia
4
Congo, Democratic Republic of
3
Ghana
3
Tanzania
3
South Africa
3
Malawi
3
Latin America and the Carribbean
3
Southern Africa
3
Guinea
2
India
2
Kenya
2
Rwanda
2
Angola
2
Nigeria
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Cameroon
1
Somalia
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Syria
1
Chad
1
Sudan
1
Benin
1
Botswana
1
El Salvador
1
Libya
1
Yemen
1
Western Pacific Region
1
Western and Central Europe
1
Palestine
1
Djibouti
1
Qatar
1
Iran
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
40
Clinical Guidelines
24
Public Health
20
Capacity Building
6
Women & Child Health
2
Key Resources
2
Pharmacy & Technologies
2
Toolboxes
NTDs
70
Rapid Response
13
Planetary Health
10
Ebola
4
Mental Health
3
Pharmacy
3
NCDs
3
HIV
2
TB
2
AMR
2
Disability
1
Natural Hazards
1
COVID-19
1
Caregiver
1
WHO convened the fifth stakeholders meeting on the elimination of HAT due to infection with Trypanosoma brucei gambiense (g-HAT) and Trypanosoma brucei rhodesiense (r-HAT) in Geneva, Switzerland, on 7–9 June 2023. The meeting was held again in person after the coronavirus disease (COVID-19) pandem
...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region wa
...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in An
...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can ...
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can ...
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field trial of a refined vector control tec
...
Un comité OMS d’experts sur la trypanosomiase humaine africaine (THA) : lutte et surveillance, s’est réuni à Genève (Suisse), du 22 au 26 avril 2013. Le Dr H. Nakatani, sous-directeur général pour le VIH/SIDA, la tuberculose, le paludisme et les maladies tropicales négligées, a ouvert la
...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African
...
Les progrès remarquables réalisés dans la lutte contre la forme à T. b. gambiense reposent sur le dépistage et le traitement curatif, une stratégie qui interrompt la transmission en réduisant le réservoir de parasites chez l’être humain. Parfois, cette
approche a été combinée avec des
...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can be
...
DNDi’s long-term goal for sleeping sickness, also known as human African trypanosomiasis (HAT), is to develop and register two new drugs that are effective against both Stage 1 and Stage 2 of the
...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
DNDi is now striving to make fexinidazole available to the majority of people who have T.b. gambiense sleeping sickness. We are supporting a three-year access and pharmacovigilance study that began in 2020 and have so far carried out in-country training of relevant staff in 250 hospitals and
...
In May the Sixty-sixth World Health Assembly adopted resolution WHA66.12 (1) on 17 neglected tropical diseases (NTDs). Among other measures, the resolution urges Member States to:
• ensure country ownership of prevention, control, elimination and eradication programmes;
• expand and implemen
...
Situation Analaysis and Needs Assessment
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra
...
